Psychology & Intimacy Immunotherapy Offers Promising New Avenue for Treatment-Resistant Depression, University of Bristol Study Reveals June 4, 2026 Rebecca Shoemaker A groundbreaking clinical trial led by researchers at the University of Bristol has unveiled a potentially transformative approach to treating difficult-to-manage depression, suggesting that immunotherapy could offer a novel therapeutic…
Psychology & Intimacy Immunotherapy Shows Promise as a Novel Approach for Treatment-Resistant Depression May 28, 2026 Rebecca Shoemaker A groundbreaking clinical trial led by the University of Bristol suggests that immunotherapy, a treatment modality traditionally employed for conditions like cancer and autoimmune diseases, could offer a transformative new…
Sexual Health & Medical Wellness Zoliflodacin Emerges as Promising Single-Dose Oral Treatment for Drug-Resistant Gonorrhea Following Successful Phase 3 Clinical Trials May 28, 2026 Susilo Ahmad Researchers are poised to revolutionize the treatment landscape for gonorrhea with the successful completion of a late-stage phase 3 clinical trial for a novel oral medication, zoliflodacin. Published in the…
Sexual Health & Medical Wellness New antibiotic pill shows promise against drug-resistant gonorrhea May 20, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler and more effective way to treat gonorrhea, particularly strains that have developed resistance to existing antibiotics,…
Sexual Health & Medical Wellness Breakthrough Oral Medication Zoliflodacin Nears Approval, Offering New Hope in the Global Fight Against Drug-Resistant Gonorrhea May 13, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness New antibiotic pill shows promise against drug-resistant gonorrhea May 6, 2026 Susilo Ahmad A significant breakthrough in the global fight against sexually transmitted infections (STIs) is on the horizon, as researchers announce promising results for zoliflodacin, a novel oral medication designed to treat…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Oral Solution in the Global Battle Against Drug-Resistant Gonorrhea April 28, 2026 Susilo Ahmad Researchers are heralding a significant advancement in the fight against gonorrhea, a pervasive sexually transmitted infection, with the development of a novel oral medication named zoliflodacin. This investigational drug holds…
Psychology & Intimacy Revolutionary Accelerated TMS Offers Hope for Treatment-Resistant Depression in Just Five Days April 22, 2026 Rebecca Shoemaker For millions grappling with depression, the promise of antidepressant medications often falls short, leaving them in a persistent state of struggle. In these challenging cases, Transcranial Magnetic Stimulation (TMS) has…
Sexual Health & Medical Wellness Zoliflodacin Offers New Hope in the Global Fight Against Drug-Resistant Gonorrhea with Promising Phase 3 Trial Results. April 21, 2026 Susilo Ahmad A significant breakthrough in the treatment of gonorrhea, one of the world’s most prevalent and increasingly drug-resistant sexually transmitted infections (STIs), has emerged with the successful conclusion of a late-stage…
Psychology & Intimacy Unraveling Ketamine’s Mysteries: Japanese Study Reveals How Brain Receptors Respond to Treatment-Resistant Depression Therapy April 18, 2026 Rebecca Shoemaker Major depressive disorder (MDD) stands as a formidable global health challenge, recognized as a primary contributor to disability worldwide. For a significant portion of individuals diagnosed with depression, the efficacy…
